Table 2.
Clinical ∆Age | Inflammatory ∆Age | |||||
---|---|---|---|---|---|---|
Events/N | HR (95% CI) | p Value | Events/N | HR (95% CI) | p Value | |
MV Adjusted | MV Adjusted | |||||
Mortality | 490/2,532 | 1.04 (1.03, 1.05) | 1.0 × 10−9 | 718/3,140 | 1.05 (1.04, 1.06) | <2 × 10−16 |
CVD | 310/2,400 | 1.05 (1.03, 1.06) | 4.7 × 10−7 | 413/2,944 | 1.04 (1.03, 1.05) | 1.8 × 10−13 |
Cancer | 411/2,329 | 1.01 (0.998, 1.03) | .08 | 510/2,859 | 1.01 (1.00, 1.02) | .014 |
Note: CI = confidence interval; CVD = cardiovascular disease; HR = hazard ratio; MV = multivariable. Median follow-up time 14.4–14.7 years across all outcomes. Covariates: age, sex, current smoking, diabetes, hypertension treatment, lipid treatment, mortality only additionally adjusted for prevalent CVD and prevalent cancer.
aEach outcome is a separate model.